Delivery Order SPE2DB20D2014-SPE2DB25FB69E
Award Date
4/21/25
Potential Completion Date
4/22/25
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB25D3201|SPE2DB25FNSRM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,441.56 firm fixed-price delivery order is for the supply of 4,568,038,058 units of the medication Mycophenolate 500 mg Tablet. The contract has an ultimate completion date of April 28, 2025 and does not utilize a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mycophenolate 500 mg tablets. The firm-fixed-price delivery order has a ceiling value of $2,991.75 and a period of performance through April 16, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,717.88 firm fixed-price delivery order is for the supply of 4,563,279,114 units of mycophenolic acid delayed-release 360 mg tablets in 120-count packages. The contract has a period of performance through January 10, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FDYX8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,117.97 delivery order contract is for the supply of Mycophenolic Acid delayed-release tablets, 360 mg, in quantities of 120 per bottle. The contract is a firm fixed-price agreement with a period of performance through February 7, 2024. This award is not designated as a...
This federal contract award is for the delivery of MYCOPHENOLATE 500 MG TABLET 500S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,677.66 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,677.66 and an ultimate completion date of March 20, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, worth $2,603.54, is for the supply of MYCOPHENOLATE 500 MG TABLET 500S, a medical product. The contract has an ultimate completion date of November 16, 2023 and is a Delivery Order with a Firm Fixed Price pricing type. This contract award is not designated with a set-aside....
This federal contract award, SPE2DB25D3005|SPE2DB25FQEMQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,019.85 firm fixed-price delivery order is for the supply of 4,567,999 units of the medication Mycophenolate 250 mg capsules. The contract has an ultimate completion date of April 23, 2025 and was awarded on April 22, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MYCOPHENOLATE 500 MG TABLET 500S. The contract, valued at $1,388.16, has a completion date of February 23, 2024. AmerisourceBergen Drug Corp serves as the prime contractor for this order, which is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
This federal contract award, valued at $1,125.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567438693 MYCOPHENOLATE 500 MG TABLET 100S, a pharmaceutical product, with a performance period running through March 4, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, to provide 4,565,265,370 units of Mycophenolate 200 mg/ml suspension, a critical pharmaceutical product. The contract has a total ceiling value of $1,271.31 and an ultimate completion date of July 29, 2024. This award is not designated as a set-aside contract. Amerisourcebergen has been awarded numerous federal contracts by...